LEGN
Legend Biotech Corp
NASDAQ · Healthcare · Biotechnology · US
$17.61
+0.17%Forward multiples
Based on analyst estimates
- P/E forward
- 41.06x
- P/E 2026E
- —
- P/E 2027E
- 29.80x
- P/E 2028E
- 16.43x
- P/S forward
- 2.12x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.79x
- Price / sales
- 2.69x
- Price / cash flow
- -18.71x
Enterprise value
- Enterprise value
- $2.7B
- EV / sales
- 2.15x
- EV / EBITDA
- -378.04x
- EV / EBIT
- -48.77x
- Market cap
- $3.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026